MNKD Shares Outstanding History
Below is a table of the MNKD shares outstanding history going back to 3/3/2017:

Date MNKD Shares Outstanding
3/3/201795.73M
3/10/201795.78M
5/5/2017101.01M
8/1/2017104.68M
10/31/2017117.15M
2/9/2018120.47M
4/24/2018140.03M
7/17/2018152.99M
10/22/2018159.60M
2/14/2019187.34M
4/15/2019187.78M
7/16/2019189.62M
10/31/2019206.41M
2/13/2020212.30M
4/13/2020213.14M
7/13/2020229.17M
10/26/2020232.60M
2/12/2021247.16M
4/30/2021249.16M
7/30/2021249.66M
10/29/2021251.26M
2/11/2022251.80M
4/29/2022252.57M

Also see: MNKD Market Cap History
MNKD YTD Return
MNKD Historical Shares Outstanding:
+20.70% CAGR
MNKD Historical Shares Outstanding: +20.70% CAGR

Mouse over chart for data details
3/3/2017 ...4/29/2022
MannKind is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases. Co.'s primary product, Afrezza (insulin human) Inhalation Powder, is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. Co. collaborates with United Therapeutics to develop an inhaled formulation of treprostinil known as Tyvaso DPI. We show 23 historical shares outstanding datapoints in our coverage of MNKD's shares outstanding history.

Understanding the changing numbers of MNKD shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like MNKD versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching MNKD by allowing them to research MNKD shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree MNKD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
MannKind (MNKD) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

MNLO Shares Outstanding History
MNOV Shares Outstanding History
MNPR Shares Outstanding History
MNTA Shares Outstanding History
MODD Shares Outstanding History
MODV Shares Outstanding History
MOH Shares Outstanding History
MORF Shares Outstanding History
MOTS Shares Outstanding History
MOVE Shares Outstanding History
More Healthcare companies »

 

MNKD Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.